Search

Search Constraints

You searched for: Author/Creator Symeonidis, Argiris

Search Results

21. Risk factors for cardiovascular disease mortality in patients with myelodysplastic syndromes: A nationwide, registry‐based cohort study. Issue 1 (1st July 2020)

22. Risk factors for cardiovascular disease mortality in patients with myelodysplastic syndromes: A nationwide, registry‐based cohort study. Issue 1 (1st July 2020)

23. Risk factors for cardiovascular disease mortality in patients with myelodysplastic syndromes: A nationwide, registry‐based cohort study. Issue 1 (1st July 2020)

24. Role of Genomic Biomarkers in Increasing Fetal Hemoglobin Levels Upon Hydroxyurea Therapy and in β-Thalassemia Intermedia: A Validation Cohort Study. (2nd January 2019)

25. SARS‐CoV‐2 persistence and non‐protective immunity in infected haematological patients. (20th November 2020)

26. Subdiaphragmatic extranodal localizations at diagnosis of primary mediastinal large B-cell lymphoma: an impressive, rare presentation with no independent effect on prognosis. (August 2021)

27. The effect of 5‐azacytidine treatment delays and dose reductions on the prognosis of patients with myelodysplastic syndrome: how to optimize treatment results and outcomes. (30th August 2020)

28. The prognostic significance of chromosome 17 abnormalities in patients with myelodysplastic syndrome treated with 5‐azacytidine: Results from the Hellenic 5‐azacytidine registry. (21st March 2019)

29. The prognostic significance of macrocytosis in patients with myelodysplastic neoplasms. Issue 5 (1st March 2023)

30. The prognostic value of monosomal karyotype (MK) in higher‐risk patients with myelodysplastic syndromes treated with 5‐Azacitidine: A retrospective analysis of the Hellenic (Greek) Myelodysplastic syndromes Study Group. Issue 7 (16th May 2018)